Refer to Table 1 for a comparison of baseline characteristics between the two patient groups, including age, gender, BP, HR, NYHA classification, comorbidities, coronary artery disease risk factors, NT-proBNP, cTNI, Hb, liver and kidney function, electrolytes, lipid profile, FBG, HbA1c, cardiac ultrasound, clinical background medications, and non-pharmacological treatments. The gene discussed is GSTM1; the disease is coronary artery disorder.